The pharma company said it expects more approvals through the year following positive results from a Phase 3 trial.

The revitalisation of GSK's blood cancer therapy Blenrep has continued with a second regulatory approval, in Japan, as a ...

Microsoft launches Discovery platform that uses agentic AI to compress years of scientific research into days, transforming R&D across pharmaceuticals, materials science, and semiconductor industries.

The 25,000-square-foot center is opening with a staff of 35, but that number is expected to double over the next two years.

Patients were randomised 1:1 to receive Nucala 100mg or placebo subcutaneously every four weeks in addition to standard ...

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

Sarah Michelle Gellar revealed former ‘Buffy the Vampire Slayer’ stars’ kids auditioned for the revival, shocking Alyson ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

(Alliance News) - GSK PLC on Monday said it has received approval in Japan for Blenrep combinations in the treatment of adults with relapsed or refractory multiple myeloma.

A 25-year-old woman was shot and killed on a West Conshohocken sidewalk early Sunday morning, and her boyfriend has been ...

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of GSK (GSK) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...

Tezepelumab demonstrated clinically relevant benefits in specific inflammatory subtypes of COPD - an historically underserved ...